Cargando…
Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System
Purpose. To evaluate the contribution of the ocular risk factors in the conversion of the fellow eye of patients with unilateral exudative AMD, using a novel semiautomated grading system. Materials and Methods. Single-center, retrospective study including 89 consecutive patients with unilateral exud...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910538/ https://www.ncbi.nlm.nih.gov/pubmed/24555130 http://dx.doi.org/10.1155/2013/464218 |
_version_ | 1782301984064274432 |
---|---|
author | Marques, João Pedro Costa, Miguel Melo, Pedro Oliveira, Carlos Manta Pires, Isabel Cachulo, Maria Luz Figueira, João Silva, Rufino |
author_facet | Marques, João Pedro Costa, Miguel Melo, Pedro Oliveira, Carlos Manta Pires, Isabel Cachulo, Maria Luz Figueira, João Silva, Rufino |
author_sort | Marques, João Pedro |
collection | PubMed |
description | Purpose. To evaluate the contribution of the ocular risk factors in the conversion of the fellow eye of patients with unilateral exudative AMD, using a novel semiautomated grading system. Materials and Methods. Single-center, retrospective study including 89 consecutive patients with unilateral exudative AMD and ≥3 years of followup. Baseline color fundus photographs were graded using an innovative grading software, RetmarkerAMD (Critical Health SA). Results. The follow-up period was 60.9 ± 31.3 months. The occurrence of CNV was confirmed in 42 eyes (47.2%). The cumulative incidence of CNV was 23.6% at 2 years, 33.7% at 3 years, 39.3% at 5 years, and 47.2% at 10 years, with a mean annual incidence of 12.0% (95% CI = 0.088–0.162). The absolute number of drusen in the central 1000 and 3000 μm (P < 0.05) and the absolute number of drusen ≥125 µm in the central 3000 and 6000 µm (P < 0.05) proved to be significant risk factors for CNV. Conclusion. The use of quantitative variables in the determination of the OR of developing CNV allowed the establishment of significant risk factors for neovascularization. The long follow-up period and the innovative methodology reinforce the value of our results. This trial is registered with ClinicalTrials.gov NCT00801541. |
format | Online Article Text |
id | pubmed-3910538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-39105382014-02-19 Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System Marques, João Pedro Costa, Miguel Melo, Pedro Oliveira, Carlos Manta Pires, Isabel Cachulo, Maria Luz Figueira, João Silva, Rufino ISRN Ophthalmol Clinical Study Purpose. To evaluate the contribution of the ocular risk factors in the conversion of the fellow eye of patients with unilateral exudative AMD, using a novel semiautomated grading system. Materials and Methods. Single-center, retrospective study including 89 consecutive patients with unilateral exudative AMD and ≥3 years of followup. Baseline color fundus photographs were graded using an innovative grading software, RetmarkerAMD (Critical Health SA). Results. The follow-up period was 60.9 ± 31.3 months. The occurrence of CNV was confirmed in 42 eyes (47.2%). The cumulative incidence of CNV was 23.6% at 2 years, 33.7% at 3 years, 39.3% at 5 years, and 47.2% at 10 years, with a mean annual incidence of 12.0% (95% CI = 0.088–0.162). The absolute number of drusen in the central 1000 and 3000 μm (P < 0.05) and the absolute number of drusen ≥125 µm in the central 3000 and 6000 µm (P < 0.05) proved to be significant risk factors for CNV. Conclusion. The use of quantitative variables in the determination of the OR of developing CNV allowed the establishment of significant risk factors for neovascularization. The long follow-up period and the innovative methodology reinforce the value of our results. This trial is registered with ClinicalTrials.gov NCT00801541. Hindawi Publishing Corporation 2013-07-30 /pmc/articles/PMC3910538/ /pubmed/24555130 http://dx.doi.org/10.1155/2013/464218 Text en Copyright © 2013 João Pedro Marques et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Marques, João Pedro Costa, Miguel Melo, Pedro Oliveira, Carlos Manta Pires, Isabel Cachulo, Maria Luz Figueira, João Silva, Rufino Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System |
title | Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System |
title_full | Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System |
title_fullStr | Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System |
title_full_unstemmed | Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System |
title_short | Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System |
title_sort | ocular risk factors for exudative amd: a novel semiautomated grading system |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910538/ https://www.ncbi.nlm.nih.gov/pubmed/24555130 http://dx.doi.org/10.1155/2013/464218 |
work_keys_str_mv | AT marquesjoaopedro ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem AT costamiguel ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem AT melopedro ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem AT oliveiracarlosmanta ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem AT piresisabel ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem AT cachulomarialuz ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem AT figueirajoao ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem AT silvarufino ocularriskfactorsforexudativeamdanovelsemiautomatedgradingsystem |